i3 Health Podcast Podcast Por i3 Health arte de portada

i3 Health Podcast

i3 Health Podcast

De: i3 Health
Escúchala gratis

i3 Health’s mission is to enhance the proficiency of the interprofessional healthcare team by providing evidence-based, fair-balanced CME/NCPD/CPE-approved activities that address identified professional practice gaps and unmet educational needs.All rights reserved Ciencia
Episodios
  • 252NSCLC zongertinib update podcast
    Apr 3 2026
    Click here to view the full CME/NCPD/CPE/AAPA activity and hear additional insights on the HER2-mutant NSCLC treatment landscape! https://i3health.com/course-information/nsclc-advances The FDA’s recent expanded approval of zongertinib marks a significant milestone in the treatment of non-small cell lung cancer (NSCLC). As the first oral human epidermal growth factor receptor 2 (HER2) inhibitor to move into the frontline setting, this therapy offers a new standard of care for patients with metastatic or unresectable non-squamous NSCLC harboring HER2 mutations. Following the approval, Beth Sandy, Thoracic Oncology Nurse Practitioner at the University of Pennsylvania, sat down to explore its clinical implications, including efficacy data, side effect management, and the potential of having a once-daily oral pill for improving patient experiences.
    Más Menos
    6 m
  • The Future of Hemophilia: New Data, New Guidance, New Outcomes with Robert F. Sidonio, Jr., MD, MSc
    Mar 25 2026
    Hemophilia care is evolving faster than ever. Dr. Robert Sidonio, Jr., a leading expert from Children’s Healthcare of Atlanta, joins us to discuss the latest breakthroughs in research and clinical trials. From navigating new treatment options to the importance of personalized patient selection, Dr. Sidonio shares the "real-world" perspective clinicians need to stay ahead. Listen now to discover what the future holds for hemophilia management! Click here to complete the activity, Raising the Bar for Hemophilia Management, and claim your CME credit: https://bit.ly/3Ini6vj
    Más Menos
    10 m
  • Advancing Care in Systemic Mastocytosis: Expert Strategies with Dr. Mariana Castells - Module 2
    Mar 13 2026
    Treatment for systemic mastocytosis (SM) has evolved fast—are your management strategies keeping up? Join Dr. Castells as she dives into the latest advances in SM therapy, including how and when to leverage tyrosine kinase inhibitors, and how to collaborate across specialties to tailor care that truly meets each patient’s needs. Packed with practical pearls and forward‑looking insights, this episode will help you elevate symptom control, safety, and quality of life for your patients. Listen now before this accredited activity expires on April 15! Click here to claim your CME/NCPD/AAPA credit: https://bit.ly/4cxzgAK
    Más Menos
    28 m
Todavía no hay opiniones